219 related articles for article (PubMed ID: 8615751)
21. Kinetics of adenylate metabolism in human and rat myocardium.
Tavenier M; Skladanowski AC; De Abreu RA; de Jong JW
Biochim Biophys Acta; 1995 Jun; 1244(2-3):351-6. PubMed ID: 7599155
[TBL] [Abstract][Full Text] [Related]
22. Regulation of soluble 5'-nucleotidase I from rabbit heart.
Yamazaki Y; Collinson AR; Truong VL; Lowenstein JM
Adv Exp Med Biol; 1989; 253B():107-11. PubMed ID: 2558529
[TBL] [Abstract][Full Text] [Related]
23. Enzymatic properties and physiological roles of cytosolic 5'-nucleotidase II.
Itoh R
Curr Med Chem; 2013; 20(34):4260-84. PubMed ID: 23992315
[TBL] [Abstract][Full Text] [Related]
24. Contribution of cytosolic and membrane-bound 5'-nucleotidases to cardiac adenosine production.
Darvish A; Pomerantz RW; Zografides PG; Metting PJ
Am J Physiol; 1996 Nov; 271(5 Pt 2):H2162-7. PubMed ID: 8945937
[TBL] [Abstract][Full Text] [Related]
25. AMP and IMP dephosphorylation by soluble high- and low-Km 5'-nucleotidases.
Spychala J; Madrid-Marina V; Nowak PJ; Fox IH
Am J Physiol; 1989 Mar; 256(3 Pt 1):E386-91. PubMed ID: 2538071
[TBL] [Abstract][Full Text] [Related]
26. The bifunctional cytosolic 5'-nucleotidase: regulation of the phosphotransferase and nucleotidase activities.
Pesi R; Turriani M; Allegrini S; Scolozzi C; Camici M; Ipata PL; Tozzi MG
Arch Biochem Biophys; 1994 Jul; 312(1):75-80. PubMed ID: 8031149
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of human cytosolic 5'-nucleotidase II: insights into allosteric regulation and substrate recognition.
Walldén K; Stenmark P; Nyman T; Flodin S; Gräslund S; Loppnau P; Bianchi V; Nordlund P
J Biol Chem; 2007 Jun; 282(24):17828-36. PubMed ID: 17405878
[TBL] [Abstract][Full Text] [Related]
28. Immunogold localization of adenosine 5'-monophosphate-specific cytosolic 5'-nucleotidase in dog heart.
Darvish A; Postlewaite JJ; Metting PJ
Hypertension; 1993 Jun; 21(6 Pt 2):906-10. PubMed ID: 8505099
[TBL] [Abstract][Full Text] [Related]
29. Nucleotide and nucleoside analogues as inhibitors of cytosolic 5'-nucleotidase I from heart.
Garvey EP; Lowen GT; Almond MR
Biochemistry; 1998 Jun; 37(25):9043-51. PubMed ID: 9636049
[TBL] [Abstract][Full Text] [Related]
30. Cytosolic 5'-nucleotidase/nucleoside phosphotransferase: a nucleoside analog activating enzyme?
Turriani M; Pesi R; Nardone A; Turchi G; Sgarrella F; Ipata PL; Tozzi MG
J Biochem Toxicol; 1994 Feb; 9(1):51-7. PubMed ID: 8151632
[TBL] [Abstract][Full Text] [Related]
31. The functional logic of cytosolic 5'-nucleotidases.
Ipata PL; Balestri F
Curr Med Chem; 2013; 20(34):4205-16. PubMed ID: 23992316
[TBL] [Abstract][Full Text] [Related]
32. Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies.
Galmarini CM; Jordheim L; Dumontet C
Leuk Lymphoma; 2003 Jul; 44(7):1105-11. PubMed ID: 12916861
[TBL] [Abstract][Full Text] [Related]
33. Expression and purification of the 5'-nucleotidase YitU from Bacillus species: its enzymatic properties and possible applications in biotechnology.
Yusupova YR; Skripnikova VS; Kivero AD; Zakataeva NP
Appl Microbiol Biotechnol; 2020 Apr; 104(7):2957-2972. PubMed ID: 32040605
[TBL] [Abstract][Full Text] [Related]
34. Altered properties of human T-lymphoblast soluble low Km 5'-nucleotidase: comparison with B-lymphoblast enzyme.
Madrid-Marina V; Lestan B; Nowak PJ; Fox IH; Spychala J
Leuk Res; 1993 Mar; 17(3):231-40. PubMed ID: 8450671
[TBL] [Abstract][Full Text] [Related]
35. 5'-Nucleotidase activity and adenosine formation in stimulated, hypoxic and underperfused rat heart.
Headrick JP; Willis RJ
Biochem J; 1989 Jul; 261(2):541-50. PubMed ID: 2549975
[TBL] [Abstract][Full Text] [Related]
36. Endo 5'-nucleotidase in healthy peripheral blood lymphocytes. Inhibition by alpha beta methylene adenosine 5'-diphosphate.
Pizzichini M; Marinello E; Rosi F; Bela Agostinho A; Tabucchi A; Carlucci F; Vannoni D; Francini G; Petrioli R; Pagani R
Biochem Soc Trans; 1996 Feb; 24(1):48S. PubMed ID: 8674719
[No Abstract] [Full Text] [Related]
37. A specific inhibitor of heart cytosolic 5'-nucleotidase I attenuates hydrolysis of adenosine 5'-monophosphate in primary rat myocytes.
Garvey EP; Prus KL
Arch Biochem Biophys; 1999 Apr; 364(2):235-40. PubMed ID: 10190979
[TBL] [Abstract][Full Text] [Related]
38. IMP degradative capacity in rat skeletal muscle fiber types.
Tullson PC; Terjung RL
Mol Cell Biochem; 1999 Sep; 199(1-2):111-7. PubMed ID: 10544959
[TBL] [Abstract][Full Text] [Related]
39. Application of solid-phase extraction on anion-exchange cartridges to quantify 5'-nucleotidase activity.
Janero DR; Yarwood C; Thakkar JK
J Chromatogr; 1992 Jan; 573(2):207-18. PubMed ID: 1601953
[TBL] [Abstract][Full Text] [Related]
40. The phosphotransferase activity of cytosolic 5'-nucleotidase; a purine analog phosphorylating enzyme.
Banditelli S; Baiocchi C; Pesi R; Allegrini S; Turriani M; Ipata PL; Camici M; Tozzi MG
Int J Biochem Cell Biol; 1996; 28(6):711-20. PubMed ID: 19927594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
